Induction of intestinal damage by rofecoxib, the selective COX-2 inhibitor, under inhibition of nitric oxide production in rats

Author： Ohno Ryoko   Miyazawa Tohru   Hayashi Yujiro   Kanatsu Kenji   Tanaka Akiko   Takeuchi Koji  

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.10, Iss.4-6, 2002-12, pp. : 435-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice

By Dhir A.   Kulkarni S.  

Inflammopharmacology, Vol. 14, Iss. 5-6, 2006-12 ,pp. : 222-225

Springer Publishing Company

Access to resources Recommend Favorite

The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats

By Martin A.R.   Villegas I.   La Casa C.   Alarcon de la Lastra C.  

European Journal of Pharmacology, Vol. 481, Iss. 2, 2003-11 ,pp. : 281-291

Elsevier

Access to resources Recommend Favorite

Selective cyclooxygenase-2 inhibitor induces gastric mucosal damage in adrenalectomized rats

By Filaretova L.   Tanaka A.   Komoike Y.   Takeuchi K.  

Inflammopharmacology, Vol. 10, Iss. 4-6, 2002-12 ,pp. : 413-422

VSP

Access to resources Recommend Favorite

Clinical pharmacology of celecoxib, a COX-2 selective inhibitor

By Antoniou Katerina   Malamas Michael   Drosos Alexandros A  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1719-1732

Informa Healthcare

Access to resources Recommend Favorite

NSAID-induced small intestinal damage: role of COX inhibition

By Tanaka Akiko   Matsumoto Masahiro   Nakagiri Akari   Kato Shinichi   Takeuchi Koji  

Inflammopharmacology, Vol. 10, Iss. 4-6, 2002-12 ,pp. : 313-325

VSP

Access to resources Recommend Favorite